Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 on the page.
    Difference
    0.0%
    Check dated 2026-01-15T03:05:47.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A consolidated Locations section now lists California, Florida, Massachusetts, and Texas as study sites, replacing the separate location headers, and the page revision has been updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-24T13:48:49.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Publications section text updated to note PubMed auto-population of articles, and the page now displays Revision: v3.3.2. This replaces the earlier wording about PubMed publications and Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:44:40.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A government funding status notice was removed from the page.
    Difference
    0.3%
    Check dated 2025-11-18T07:30:02.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    No additions or deletions detected on the Study Details page for NCT02926833; the content and structure appear the same across the screenshots.
    Difference
    0.4%
    Check dated 2025-11-03T21:33:22.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    - Page now includes a government operating status notice and directs to official sources for updates. - Version updated from v3.1.0 to v3.2.0. - Adds a new resource topic: Malignant lymphoma, large B-cell, diffuse.
    Difference
    3%
    Check dated 2025-10-06T06:57:40.000Z thumbnail image

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.